Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
281
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
+467K
-
Total reported value, excl. options
-
$2.71B
-
Value change
-
+$42.6M
-
Put/Call ratio
-
6.45
-
Number of buys
-
128
-
Number of sells
-
-131
-
Price
-
$91.80
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2024
332 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2024.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 281 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 33M outstanding shares and own 89.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.23M shares), BlackRock Inc. (3.1M shares), FARALLON CAPITAL MANAGEMENT LLC (1.31M shares), ALPINE ASSOCIATES MANAGEMENT INC. (1.28M shares), FIL Ltd (1.15M shares), GOLDMAN SACHS GROUP INC (1.11M shares), Westchester Capital Management, LLC (1.02M shares), STATE STREET CORP (967K shares), MILLENNIUM MANAGEMENT LLC (859K shares), and Pentwater Capital Management LP (781K shares).
This table shows the top 281 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.